Description

Denosumab solution for injection 120mg/1.7ml is a monoclonal antibody used to treat osteoporosis and bone metastases in cancer patients. By inhibiting RANKL, it reduces bone resorption and increases bone density, thereby lowering the risk of fractures and improving patient outcomes.